Page 30 - KPJ_2011

However, economic uncertainties put a damper on
investors’ confidence in the equities market and bellwether
FBM KLCI shed 13% from its all-time high of 1,594.74 on
July 8 to end September at 1,387.13.
KPJ shares also succumbed to profit-taking that took it
to its lowest level in 26 weeks of RM3.84 that month, but
quickly regained ground and rose 17.5% over the final
three months of the year to end 2011 at a record closing
price of RM4.70 and gave shareholders a 26% capital
appreciation that year.
With a market capitalization of RM2.74 billion, KPJ also
notched up to 75th placing among the top 100 companies
by market capitalization on Bursa Malaysia at end-2011, up
from the 85th spot at end-2010, with a market capitalization
of RM2.08 billion.
Awards
Our conscious effort to build up shareholders’ confidence,
alongside the Group’s sterling performance over the past
years, helped us bag the title of Best Performing Stock
– Highest Return to Shareholder Over 3 Years (Trading/
Services) from The Edge 100 Billion Club on 13 July 2011.
This came on the heels of KPJ being named Healthcare
Service Provider of the Year by Frost and Sullivan on 13
April 2011 and securing the Innovative Leadership in
Globalisation (Healthcare) award from the Malaysian
Institute of Directors on 4 May 2011.
2011 – Year of Change
The year 2011 proved our ability to adapt to and embrace
changes, and to transform ourselves to meet the challenges
of the new age.
Boardroom Changes
On 12 January 2011, KPJ appointed a new Chairman,
Kamaruzzaman Abu Kassim, who brought a new sense of
direction on growth and development for the Group and took
KPJ smoothly through changes in the Board during that year.
During the year, independent non-executive director and
current Audit Committee member, Zainah Mustafa, was
appointed as the Chairman of the Audit Committee on 16
June 2011 to take over the responsibility from Tan Sri Dato’
Seri Arshad Ayub, who retired after contributing to and
ensuring good corporate governance and accountability
for the past 17 years as a Director as well as Chairman of
the Audit Committee.
The appointment of Dr Yoong Fook Ngian, who is also an
Independent Non-Executive Director, as Chairman of the
Group Medical Advisory Committee on 1 January 2011
has brought significant change and provided excellent
leadership to the clinical committees.
Our investment in a leadership and succession plan enabled
us to execute a seamless leadership transition, as the Group
witnessed the board changes over the year just past.
On 4 July 2011, Amiruddin Abdul Satar was appointed as
Executive Director while also retaining the portfolio of KPJ’s
Chief Operating Officer, and Abd Razak Haron was named
as Non-Independent and Non-Executive Director.
We believe that the appointment of the new Board members
will further strengthen the Group and as Chairman and
Managing Director, we will continue to give our best to this
organization and work closely with the Board and Executive
Committee members to help achieve KPJ’s objectives.
Business Strategy Review
KPJ’s transformation continued with the review and
reappraisal of business strategies to enhance efficiency
of resources, empower people and embrace new skills,
processes and technologies, with the ultimate aim of
improving services rendered to customers.
Overall, KPJ Group continued to gain the trust of the
community, attending to more than 2.6 million patients
in 2011 and is expected to provide quality care to more
customers in the coming year.
One-year share price trend Five-year share price trend
25 ANNUAL REPORT 2011